ConductScience.org, home

Paper28292983

Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application.

Kerantzas CA and 1 other. mBio, 2017. Cited by 129 papers, by iCite.

Cite this record

ConductScience Library. Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. Papers, record 28292983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28292983

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application.
PubMed
Journal
mBio
PubMed
Year
2017
PubMed
Publication types
Historical Article, Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
129
iCite
Relative citation ratio, by iCite
5.16
iCite
Revised in PubMed
2026-01-27
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kerantzas CAChristopher A
2Jacobs WR JrWilliam R

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
Drug Therapy, CombinationMajor topic
TuberculosisMajor topic
Aminosalicylic Acid
Drug Discovery
History, 20th Century
History, 21st Century
Humans
Streptomycin
United Kingdom

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI026170NIAID NIH HHSUnited StatesR01AI026170PubMed and NIHNIH RePORTER
R01 AI097548NIAID NIH HHSUnited StatesR01AI097548PubMed and NIHNIH RePORTER
R37 AI026170NIAID NIH HHSUnited StatesR01AI026170PubMed and NIHNIH RePORTER
T32 GM007288NIGMS NIH HHSUnited StatesT32GM007288PubMed and NIHNIH RePORTER
R37AI026170NIHNIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114164615PRODUCTION OF PENICILLIN IN THE UNITED STATES (1941-1946).Nature1964https://conductscience.org/library/papers/14164615PubMed
216436705Discovery of FabH/FabF inhibitors from natural products.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16436705PubMed
317278059Mutant selection window hypothesis updated.Clin Infect Dis2007https://conductscience.org/library/papers/17278059PubMed
518626052The first use of penicillin in the United States.Ann Intern Med2008https://conductscience.org/library/papers/18626052PubMed
623179675Molecular biology of drug resistance in Mycobacterium tuberculosis.Curr Top Microbiol Immunol2013https://conductscience.org/library/papers/23179675PubMed
922564842Induction of mycobacterial resistance to quinolone class antimicrobials.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22564842PubMed
1110529902Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications.Int J Tuberc Lung Dis1999https://conductscience.org/library/papers/10529902PubMed
1226985890Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.Int J Mol Sci2016https://conductscience.org/library/papers/26985890PubMed
1323768488Microbial persistence and the road to drug resistance.Cell Host Microbe2013https://conductscience.org/library/papers/23768488PubMed
1449163Short-course chemotherapy for pulmonary tuberculosis.Am Rev Respir Dis1975https://conductscience.org/library/papers/49163PubMed
1519679737The introduction of 'chemotherapy' using arsphenamine - the first magic bullet.J R Soc Med2009https://conductscience.org/library/papers/19679737PubMed
1626999656Persistence and resistance as complementary bacterial adaptations to antibiotics.J Evol Biol2016https://conductscience.org/library/papers/26999656PubMed
18413477A taxonomic study of the Penicillium chrysogenum series.Antonie Van Leeuwenhoek1977https://conductscience.org/library/papers/413477PubMed
207030377Whither short-course chemotherapy?Br J Dis Chest1981https://conductscience.org/library/papers/7030377PubMed
2111702082How many antibiotics are produced by the genus Streptomyces?Arch Microbiol2001https://conductscience.org/library/papers/11702082PubMed
2323629505Platforms for antibiotic discovery.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23629505PubMed
2713776497A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).Am Rev Respir Dis1961https://conductscience.org/library/papers/13776497PubMed
281541313Further observations on penicillin. 1941.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1541313PubMed
388863420Proposal for two new genera, Brevibacillus gen. nov. and Aneurinibacillus gen. nov.Int J Syst Bacteriol1996https://conductscience.org/library/papers/8863420PubMed
403543562The history of the therapeutic use of crude penicillin.Med Hist1987https://conductscience.org/library/papers/3543562PubMed

See all 35 referencesDownload CSV of references

Cited by102

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.

PMIDTitleJournalYearIn PapersSource
42948277Synergistic antimycobacterial activity of Piper longum and Cressa cretica extracts and their effects on the expression of rpoB, gyrA and gyrB genes in Mycobacterium tuberculosis.Med Int (Lond)2026https://conductscience.org/library/papers/42948277PubMed
42839156A Comparison of Mechanisms Driving Lesion Outcomes During Lung Tumor and Tuberculosis Granuloma Formation.Bull Math Biol2026https://conductscience.org/library/papers/42839156PubMed
42793156Membrane Disruption and Charge Neutralization Drive Synergy Between LL37-Derived Peptides and Polymyxins Against E. coli.Biomolecules2026https://conductscience.org/library/papers/42793156PubMed
42494476The Evolution of Knockdown Resistance: Genotypic and Phenotypic Insights Into Aedes aegypti Insecticide Resistance.Evol Appl2026https://conductscience.org/library/papers/42494476PubMed
42439564Dual inhibition of respiratory complexes in Mycobacterium tuberculosis results in bacterial killing.Microbiol Spectr2026https://conductscience.org/library/papers/42439564PubMed
42196226Two Worlds, One Battle: How Bacteria and Malignancies Converge on Drug Resistance.Int J Mol Sci2026https://conductscience.org/library/papers/42196226PubMed
42182461In vitro dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesions.bioRxiv2026https://conductscience.org/library/papers/42182461PubMed
41736535Antibiotic hybrids: A promising strategy to replenish the pipeline and combat antimicrobial resistance.J Microbiol2026https://conductscience.org/library/papers/41736535PubMed
41718947Antimicrobial Armageddon: The Professional Guide to Conquering Antibiotic Resistance.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/41718947PubMed
41693264Preclinical Pharmacokinetics and Pharmacodynamics of Antibiotic Adjuvants.ACS Infect Dis2026https://conductscience.org/library/papers/41693264PubMed
41599169Advancing Tuberculosis Treatment with Next-Generation Drugs and Smart Delivery Systems.Pharmaceutics2026https://conductscience.org/library/papers/41599169PubMed
41529103Defining the Mechanism of Action and Resistance of New Mycobacterium abscessus MmpL3 Inhibitors.ACS Chem Biol2026https://conductscience.org/library/papers/41529103PubMed
41281587A novel machine-learning based optimization: identifying new treatment regimens for tuberculosis.Numer Algebr Control Optim2025https://conductscience.org/library/papers/41281587PubMed
41186421Drug-resistant tuberculosis: a priority pathogen for enhanced public health research and practice.Clin Microbiol Rev2025https://conductscience.org/library/papers/41186421PubMed
41181601GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy.Front Pharmacol2025https://conductscience.org/library/papers/41181601PubMed
41083887Bacterial cell envelope-targeting antibiotics.Nat Rev Microbiol2026https://conductscience.org/library/papers/41083887PubMed
40965512Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40965512PubMed
40951570Advanced Therapeutic Interventions Targeting Mycobacterium Tuberculosis.Arch Razi Inst2025https://conductscience.org/library/papers/40951570PubMed
40934261Positive allosteric modulation of emodepside sensitive Brugia malayi SLO-1F and Onchocerca volvulus SLO-1A potassium channels by GoSlo-SR-5-69.PLoS Pathog2025https://conductscience.org/library/papers/40934261PubMed
40559793Molecular Identification and Antimicrobial Resistance Characteristics of Extended-Spectrum Beta-Lactamase Producing Klebsiella pneumoniae Isolated from Captive Wild and Migratory Birds.Vet Sci2025https://conductscience.org/library/papers/40559793PubMed

See all 102 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28292983

GET https://conductscience.org/api/papers/v1/28292983/references?page=2